CLINICAL BENEFITS OF USING THE HISTOCULTURE DRUG RESPONSE ASSAY (HDRA)Except from the Human Tumor Assay Journal by Larry Weisenthal, MD, PhD, at “weisenthal.org”:
“…patients are 7 times more likely to benefit from treatment with CCDRT (cell culture drug resistance testing) active drugs than from treatment with CCDRT inactive drugs, in scores of studies, involving thousands of patients.”Histoculture Drug Response Assay - FEATURES
APPLICATIONS OF THE HISTOCULTURE DRUG RESPONSE ASSAY
- Three dimensional culture
- Indivudualized cancer patient tumor sensitivity
- Drug discovery
- Prostate androgen sensitivity assay
- High correlation to clinical drug sensitivity
- The HDRA determines both drug sensitivity and resistance
Determination of Best Treatment Options For Individual Patients for all Solid Tumor Types
Determination of Optimal Treatment for Tumors Without Standard Therapy
Screening of Compound Libraries for Activity on Real Human Tumors HOW TO USE HDRA® BY ONCOLOGISTS AND PATIENTS
Telephone 858-654-2555, 800-511-2555 to have tumor transport pack sent to you.
Send fresh tumor specimen in tube provided in transport pack.
Indicate tumor type and drugs to be tested on form provided in transport pack.
Send transport pack by FedEx to AntiCancer, Inc. at 7917 Ostrow St., San Diego, CA 92111.
Chemosensitivity report will be sent by Fax/Email within 7 days.